Ipilimumab: Phase I data

In an open-label, dose-escalation Phase I trial of ipilimumab in combination with GM-CSF (sargramostim) in 18 patients, 2 of 3 patients in the highest dose arm of ipilimumab (3 mg/kg) had confirmed de...